Seven novel device or indication approvals were added to Medtech Insight's Approvals Tracker last week, including a new micro-invasive glaucoma surgery (MIGS) from Ivantis Inc.
US FDA approved Ivantis' Hydrus Microstent PMA Aug. 10 for use in conjunction with cataract surgeryto reduce intraocular pressure in...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?